Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current trends in herpetic keratitis]

C Iordănescu1

  • 1Clinica Oftalmologică, Constanţa.

Oftalmologia (Bucharest, Romania : 1990)
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Herpes simplex virus (HSV) can cause severe eye infections and remains latent in the body, leading to recurrent disease. Newer antiviral drugs like acyclovir offer more selective action than older treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[An update on the treatment of central retinal vein thrombosis (retinal vein occlusion)].

Oftalmologia (Bucharest, Romania : 1990)·2000
Same author

[Juvenile glaucoma].

Oftalmologia (Bucharest, Romania : 1990)·2000
Same author

[Current concepts in the treatment of recent and late posttraumatic glaucoma].

Oftalmologia (Bucharest, Romania : 1990)·1997
Same author

[Raverdino's operation, a procedure to resolve lacrimal dacryostenosis with deficient pituitary mucosa].

Oftalmologia (Bucharest, Romania : 1990)·1996
Same author

[A case of Lobstein's osteopsathyrosis].

Oftalmologia (Bucharest, Romania : 1990)·1995
Same author

[Ocular manifestations in progeria].

Oftalmologia (Bucharest, Romania : 1990)·1995
Same journal

[Macular serpiginous choroiditis complicated by macular hole].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Therapeutic approach in persistent diabetic macular edema].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Preliminary results of treatment with aflibercept].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

MANAGEMENT OF DIABETIC RETINOPATHY, PREVALENCE AND CLINICAL CLASSIFICATION.

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Changes in intraocular pressure depending on posture].

Oftalmologia (Bucharest, Romania : 1990)·2015
Same journal

[Treatment for penetrating wound caused by metallic intraocular foreign body].

Oftalmologia (Bucharest, Romania : 1990)·2015
See all related articles

Area of Science:

  • Virology
  • Ophthalmology
  • Immunology

Context:

  • Herpes simplex virus (HSV) is a significant cause of oculofacial lesions, distinct from other viruses due to lesion severity and frequent ocular involvement.
  • HSV establishes latency post-initial infection, with potential for recurrent manifestations.
  • HSV exhibits considerable antigenic variability, complicating treatment strategies.

Purpose:

  • To differentiate Herpes Simplex Virus (HSV) from other viral pathogens.
  • To highlight the distinct clinical presentations of HSV Type I (oculofacial) and Type II (genital) infections.
  • To review the evolution and comparative efficacy of antiviral therapies for HSV.

Summary:

  • First-generation antiviral drugs (IDU, IDC, vidarabine, TFT) for HSV exhibit significant toxicity due to poor selectivity.

Related Experiment Videos

  • Second-generation antivirals, such as acyclovir, demonstrate enhanced selectivity and improved therapeutic profiles.
  • Corticosteroids, when administered locally, are beneficial for immunopathological lesions in recurrent, severe HSV eye infections, requiring careful management alongside prophylactic antiviral chemotherapy.

    • Impact:

    • Improved understanding of HSV pathogenesis and clinical manifestations, particularly ocular involvement.
    • Advancement in antiviral therapy, moving towards more selective and less toxic treatment options.
    • Guidance on the adjunctive use of corticosteroids in managing severe, recurrent HSV eye disease, emphasizing a combined therapeutic approach.